The incidence of gestational diabetes mellitus (GDM) in pregnancy is increasing worldwide. In addition to the perinatal complications of GDM, there are also long-term health risks, as shown by the increased incidence of type 2 diabetes and cardiovascular disease. However, knowledge about the predictive factors for long-term metabolic health outcomes in women after GDM is still limited.
Autoren
- Jens Dehn
Publikation
- InFo DIABETOLOGIE & ENDOKRINOLOGIE
Related Topics
You May Also Like
- IBDmatters - Synergy effects for IBD pathways
How combination therapies lead to better treatment results
- "Patients W.A.I.T. Indicator"
Access to new drugs is becoming increasingly difficult
- Cardiometabolic research
The liver-heart axis in the pathogenesis of cardiometabolic diseases
- ASCO 2025
Supportive therapies for greater adherence and compliance
- Heart rhythm
From harmonious symphony to age-related dissonance
- Precision therapy
Targeted MET inhibition after progression with osimertinib
- Chronic cough
Differential diagnostic detective work and trial therapies
- Cancer in Europe: facts and analysis